相关实验视频

Updated: Jan 20, 2026

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

COVID-19相关囊炎:在SARS-CoV-2之后的新型尿急症

Trevor Virno¹, Nate Tomilonus¹, Joel Hart¹

¹Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, USA.

|January 19, 2026

概括

COVID-19可能会导致膀问题,如尿路急迫,这种情况被称为COVID相关囊炎 (CAC). 这份病例报告显示了COVID-19后持续急迫症的成功治疗方法,突出了生殖泌尿系统的影响.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
传染性疾病传染性疾病
病理学病理学病理学

背景情况:

COVID-19是一种全身性疾病,已知有肺,心血管和神经效应.
新出现的证据表明,生殖泌尿道,特别是膀,是COVID-19参与的重要地点.
与COVID相关的囊炎 (CAC) 是一种独特的实体,其特点是出现新的或恶化的下泌尿道症状 (LUTS),而无细菌感染.

研究的目的:

报告COVID-19后持续性泌尿急迫的病例,成功用oxybutynin治疗.
为了在CAC现有的文献中将这个案例置于背景中.
强调承认CAC及其管理的临床意义.

主要方法:

一名71岁的妇女在COVID-19后出现尿急症的病例报告.
审查CAC现有文献,包括生物标志物研究,机理分析和队列调查.
药理治疗用氧化丁尼.

主要成果:

患者在COVID-19康复后经历了持续的尿急.
用氧丁宁治疗导致了成功的症状缓解.
文献审查支持炎症性细胞因子释放和膀中的病毒受体表达作为CAC的潜在病理生理机制.

结论:

与COVID相关的囊炎 (CAC) 是COVID-19的一个重要的生殖尿路序列.
识别CAC可以防止误诊,并指导适当的管理,通常使用过度活性膀 (OAB) 框架.
这一案例凸显了在长期COVID及其更广泛的系统影响的背景下考虑膀健康的必要性.

关键词:

急性囊炎是什么情况冠状病毒疾病2019 (COVID-19) 是一种新型冠状病毒疾病.下泌尿道的症状下泌尿道的症状过度活动的膀冲动性冲动性冲动性冲动性

更多相关视频

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

Assessing Functional SARS-CoV-2 Neutralizing Antibodies

Assessing Functional SARS-CoV-2 Neutralizing Antibodies

Published on: January 15, 2026

相关概念视频

Assessing Functional SARS-CoV-2 Neutralizing Antibodies

Assessing Functional SARS-CoV-2 Neutralizing Antibodies

Source:Kelly Da Costa1, Diego Cantoni1,2, Martin Mayora-Neto1, Tobia Fantoni1,3, Nigel Temperton11Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent.2MRC-University of Glasgow Centre for Virus Research, University of Glasgow.3Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona.This video showcases a neutralization assay measuring serum efficacy in neutralizing SARS-CoV-2 viruses. It involves pseudotyped viruses, serum dilution, and...

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

This protocol aims to quantify SARS-CoV-2 RNA in wastewater and air samples to be used for wastewater-based epidemiology studies and to assess the exposure risk to SARS-CoV-2 in indoor and outdoor aerosols. This protocol also describes a tiled amplicon long-template sequencing approach for SARS-CoV-2 whole genome...

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

A citizen science project was designed to recruit San Diego residents to collect environmental samples for SARS-CoV-2. A multilingual web-based platform was created for data submission using a user-friendly mobile device interface. A laboratory information management system facilitated the collection of thousands of geographically diverse samples with real-time outcome...

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

This protocol describes the application of a novel hybrid alphavirus-SARS-CoV-2 pseudovirus (Ha-CoV-2) as a platform for rapid quantification of infectivity of SARS-CoV-2 variants and their sensitivity to neutralizing...

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

The outlined protocol describes the procedure for producing the HiBiT-receptor-binding domain protein complex and its application for fast and sensitive detection of SARS-CoV-2...

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

We present two probe-based in-house one-step RT-qPCR kits for common respiratory viruses. The first assay is for SARS-CoV-2 (N), Influenza A (H1N1 and H3N2), and Influenza B. The second is for SARS-Cov-2 (N) and MERS (UpE and ORF1a). These assays can be successfully implemented in any specialized laboratory.